The Flagellin-TLR5 Axis: Therapeutic Opportunities

Details

Serval ID
serval:BIB_5D16BD5A20D0
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
The Flagellin-TLR5 Axis: Therapeutic Opportunities
Journal
Drug News Perspect
Author(s)
Liaudet  L., Deb  A., Pacher  P., Mabley  J. G., Murthy  K. G., Salzman  A. L., Szabo  C.
ISSN
0214-0934 (Print)
Publication state
Published
Issued date
09/2002
Volume
15
Number
7
Pages
397-409
Notes
Journal article --- Old month value: Sep
Abstract
Motile bacteria synthesize large-sized surface structures known as flagella through the ordered polymerization of protein subunits. Flagellin, a protein of 40-60 kDa, is the principal constituent of the flagellum; each flagellum consists of approximately 20,000 flagellin molecules. An alignment of the amino acid sequences from different Gram-negative species shows a high degree of similarity in the amino and carboxy terminal domains. In contrast, the central hypervariable regions of these proteins are quite divergent. Recent work reveals that--in addition to playing a role in bacterial adhesion--monomeric flagellin, a protein component of flagellated bacteria, can also act as a soluble immunostimulatory and proinflammatory factor, activating the immune/inflammatory axis via the Toll-like receptor 5-nuclear factor-kappaB axis. Monocytes and macrophages, as well as intestinal and pulmonary epithelial cells, respond to monomeric flagellin at low concentrations. Administration of flagellin at doses comparable to or lower than that of bacterial lipopolysaccharide (endotoxin) can induce prominent local and systemic immune/inflammatory responses in vivo. Recognition of the flagellin-TLR5 pathway offers novel opportunities for the experimental therapy of various forms of shock, sepsis, acute respiratory distress syndrome, bacterial inflammation and infection. (c) Prous Science 2002. All rights reserved.
Pubmed
Web of science
Create date
24/01/2008 18:01
Last modification date
20/08/2019 15:15
Usage data